Search for: "Sanofi-Aventis" Results 61 - 80 of 563
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2009, 9:59 pm
District Court for the District of New Jersey has signed off on Sanofi-Aventis' settlement agreement with Sun Pharmaceutical Industries Ltd. despite the fact that Sanofi failed to exchange all relevant signature pages. [read post]
10 Nov 2010, 1:46 pm by By STEVEN M. DAVIDOFF
A state statute and a 2006 proxy vote by Genzyme add an interesting twist to a hostile takeover bid by Sanofi-Aventis and help to illustrate the difficulties of making a bid for a Massachusetts corporation. [read post]
14 Nov 2008, 2:25 am
It is produced and marketed by Procter & Gamble and Sanofi-Aventis. [read post]
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators charged eight people in Georgia with insider trading on Tuesday, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis. [read post]
28 Jul 2010, 3:47 pm by By MICHAEL J. DE LA MERCED
Sanofi-Aventis is likely to make an unsolicited offer of up to $70 a share for Genzyme, raising the stakes for what could become one of the year's biggest deal situations, people briefed on the matter told DealBook on Wednesday. [read post]
Sanofi-Aventis, the French pharmaceutical company considering an $18.6 billion bid for the U.S. biotechnology firm Genzyme, said profits jumped in the second quarter due to strong sales of its diabetes drugs and the weaker euro. [read post]
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators on Tuesday charged eight people in Georgia with insider trading, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis [read post]
31 Aug 2010, 4:30 am by By DEALBOOK
" That, in a nutshell, is the message Chris Viehbacher, the chief executive of Sanofi-Aventis, is sending the management of the biotech company Genzyme in making public his $18.5 billion offer to buy it. [read post]
26 Aug 2010, 7:03 am by Jenna Greene
A federal judge has denied a bid by Sanofi-Aventis to halt sales of a generic version of its blockbuster blood thinner Lovenox, a move which may help pave the way for the Food and Drug Administration to approve generic biologic... [read post]
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators on Tuesday charged eight people in Georgia with insider trading, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis [read post]
26 Nov 2010, 2:59 am by By CHRIS V. NICHOLSON
Henri Termeer of Genzyme told Le Figaro that he was not against Sanofi-Aventis's $18.5 billion takeover offer in principle, he just thinks it should be higher. [read post]
22 Oct 2010, 3:41 pm by By ANDREW POLLACK
Seeking to fend off a hostile takeover bid by Sanofi-Aventis, the biotechnolgy company Genzyme argued strenuously that it was worth far more than the $18.5 billion that the French drug maker is offering. [read post]
11 Feb 2011, 3:21 pm by Tom Huddleston Jr.
Plus: updates on Genzyme and Sanofi-Aventis and more deal news. [read post]
13 Sep 2010, 4:45 am by By DEALBOOK
Sanofi-Aventis, France's largest drugmaker, arranged about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme, two people familiar with the situation said. [read post]
2 Aug 2010, 2:57 am by By DEALBOOK
With activist directors driving up the price, Sanofi-Aventis could find itself shelling out at least $80 a share, or $21.3 billion, to acquire drugmaker Genzyme, Bloomberg News reported. [read post]
7 Oct 2010, 2:38 pm by By MICHAEL J. DE LA MERCED
Genzyme said Thursday that its board had again rejected an $18.5 billion takeover offer from Sanofi-Aventis of France, saying the bid remains too low. [read post]
7 May 2012, 10:42 am by Chad Bray
A former research chemist was sentenced to a year and a half in prison Monday after she admitted last year to stealing trade secrets from Sanofi-Aventis SA, the pharmaceutical company. [read post]
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators on Tuesday charged eight people in Georgia with insider trading, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis [read post]
6 Feb 2011, 12:25 pm by By MICHAEL J. DE LA MERCED
The two companies are in the final stages of discussions over what will likely be a $19 billion takeover of Genzyme by Sanofi-Aventis, though the talks have taken longer than expected. [read post]
10 Sep 2010, 2:03 am by By DEALBOOK
French drugmaker Sanofi-Aventis poured cold water on reports it had raised its offer for Genzyme, saying it was sticking to its bid of $18.5 billion, or $69 per share, Reuters reported. [read post]